The current stock price of IMAC is 1.01 USD. In the past month the price increased by 2.54%. In the past year, price decreased by -35.67%.
ChartMill assigns a technical rating of 5 / 10 to IMAC. When comparing the yearly performance of all stocks, IMAC turns out to be only a medium performer in the overall market: it outperformed 43.31% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to IMAC. IMAC has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months IMAC reported a non-GAAP Earnings per Share(EPS) of -0.38. The EPS increased by 13.64% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -76.98% | ||
| ROA | -48.41% | ||
| ROE | N/A | ||
| Debt/Equity | 0.01 |
8 analysts have analysed IMAC and the average price target is 3.59 USD. This implies a price increase of 255.15% is expected in the next year compared to the current price of 1.01.
For the next year, analysts expect an EPS growth of 2.98% and a revenue growth 21.45% for IMAC
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| HCA | HCA HEALTHCARE INC | 16.55 | 117.235B | ||
| THC | TENET HEALTHCARE CORP | 12.17 | 17.224B | ||
| UHS | UNIVERSAL HEALTH SERVICES-B | 9.18 | 13.525B | ||
| ENSG | ENSIGN GROUP INC/THE | 26.77 | 11.419B | ||
| EHC | ENCOMPASS HEALTH CORP | 17.96 | 10.018B | ||
| PACS | PACS GROUP INC | 18.7 | 5.775B | ||
| BKD | BROOKDALE SENIOR LIVING INC | N/A | 3.674B | ||
| CON | CONCENTRA GROUP HOLDINGS PAR | 15.55 | 3.016B | ||
| NHC | NATIONAL HEALTHCARE CORP | N/A | 2.482B | ||
| SEM | SELECT MEDICAL HOLDINGS CORP | 11.85 | 1.916B |
View all stocks in the Health Care Facilities Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find more growth stocks the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
IMAC Holdings, Inc. provides medical services through integrated medicine and chiropractic regeneration centers. The company is headquartered in Brentwood, Tennessee and currently employs 154 full-time employees. The company went IPO on 2019-02-13. The firm provides movement, orthopedic and neurological therapies through its chain of Innovative Medical Advancements and Care (IMAC) Regeneration Centers. The Company, through its outpatient medical clinics, provide conservative, non-invasive medical treatments to help patients with back pain, knee pain, joint pain, ligament and tendon damage, and other related soft tissue conditions. Its BACKSPACE retail spine health and wellness treatment centers deliver chiropractic care within Walmart locations. The firm is also conducting a Phase I clinical trial evaluating a mesenchymal stem cell therapy candidate for bradykinesia due to Parkinson's disease. The firm operates approximately 17 outpatient medical clinics in six states and four BackSpace locations in two states of United States.
IMAC HOLDINGS INC
1605 Westgate Cir
Brentwood TENNESSEE 37027 US
CEO: Jeffrey S. Ervin
Employees: 154
Phone: 18442664622.0
IMAC Holdings, Inc. provides medical services through integrated medicine and chiropractic regeneration centers. The company is headquartered in Brentwood, Tennessee and currently employs 154 full-time employees. The company went IPO on 2019-02-13. The firm provides movement, orthopedic and neurological therapies through its chain of Innovative Medical Advancements and Care (IMAC) Regeneration Centers. The Company, through its outpatient medical clinics, provide conservative, non-invasive medical treatments to help patients with back pain, knee pain, joint pain, ligament and tendon damage, and other related soft tissue conditions. Its BACKSPACE retail spine health and wellness treatment centers deliver chiropractic care within Walmart locations. The firm is also conducting a Phase I clinical trial evaluating a mesenchymal stem cell therapy candidate for bradykinesia due to Parkinson's disease. The firm operates approximately 17 outpatient medical clinics in six states and four BackSpace locations in two states of United States.
The current stock price of IMAC is 1.01 USD. The price increased by 2% in the last trading session.
IMAC does not pay a dividend.
IMAC has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
IMAC HOLDINGS INC (IMAC) will report earnings on 2022-08-23, before the market open.